Signed in as:
filler@godaddy.com
Accelerating Access To Innovative Medicines
Our Purpose
Innovation in medicine changes lives. But, this can only happen when that innovation can be accessed.
We exist to help more people benefit from life-transforming medicines by making technology the enabler, not the barrier.
We are a small Australian medtech company based in Sydney and the USA. For 20 years working in the pharmaceutical industry our founder has been deeply passionate about making innovative therapies affordable and available to everyday people. When a close family friend was diagnosed with cancer and struggled to find, and then access, new medicines he was compelled to leave his job in pharma and start a venture the would finally deliver much needed technology innovation to the healthcare industry.
He partnered with a tech guru (also from pharma) and together they imagined the creation of the first all-encompassing, easy- and fast-to-launch medicines access platform. They are proud to have made this happen and cannot wait to share it with the world (or at least Australia to start)!
Our Values
We reward kindness
Avoid ego
Seek joy
Are paranoid about mediocrity &
Impatient for change.
Our Team
Jason Macey
Jason is the Director and Founder. He has a Bachelor of Science with first-class honours in pharmacology and an executive Masters of Business Administration. He has worked in pharma for 20+ years and has diverse expertise in clinical trials, medical, commercial and diagnostic roles. He has launched many innovative medicines in the Australian market – many with complicated co-dependent submission strategies.
Jason lives in Sydney, loves the outdoors and with his DIY skills will one day be a contestant on The Block.
Mike Ward
Mike is a Director and the humble tech genius of the business. He has arguably the most coding experience for patient access programs in Australia having worked on systems for all major companies for over 15 years. His app development is amazing too and he has some reaching the top 10 downloads on the app store.
Mike is a family man and in his spare time is passionate about martial arts.
Frank Chidwick
With a background in hospital pharmacy, Frank has over 20 years of experience in the pharmaceutical industry and is an expert at managing Patient Access and Support programs as well as Medical Information. He understands the operational challenges and intricacies of running Access Programs across multiple therapeutic areas and is driven by process to improve efficiency.
In his spare time Frank writes children’s books and is nurturing a passion for permaculture.
Dana Macey
Dana is the Director of Strategy and Operations with two decades developing expertise in strategy, brand experience, customer solutions and digital marketing. She is passionate about genuinely understanding a business' customer, their drivers and lifecycle journey in order to create valuable and sustainable business marketing strategies.
Outside of work, Dana enjoys time with her family and has a keen interest in architecture and design.
Support crew
Cruiser is our Customer Loyalty Manager.
As an Australian Blue Cattledog, loyalty is his number one priority and he takes his job very seriously (as you can see).
In order to have full-service capabilities we rely on a collective talent pool of vibrant, purpose-led individuals. We work with medical, marketing, creative, copywriters and nursing professionals depending on the needs of our clients. These people all have the Imagine If ethos and we're proud to work with them.
Coming Soon - Our Passion Project
CancerCUBE is a platform that brokers the access and awareness of innovative medicines for oncology. It is built for busy doctors to allow them a 'one-stop-shop' so that they have visibility of all the medicines access programs in one place.
Access programs can be searched by drug, biomarker, company, and cost.
The platform was recently awarded a NSW Government Innovation Grant and we are presently working with doctors to add valuable features that will make it even better and to bring it to market soon.
